Nothing Special   »   [go: up one dir, main page]

DE69530910D1 - Medizinische zusammensetzungen enthaltend ein sialinsäurederivat - Google Patents

Medizinische zusammensetzungen enthaltend ein sialinsäurederivat

Info

Publication number
DE69530910D1
DE69530910D1 DE69530910A DE69530910A DE69530910D1 DE 69530910 D1 DE69530910 D1 DE 69530910D1 DE 69530910 A DE69530910 A DE 69530910A DE 69530910 A DE69530910 A DE 69530910A DE 69530910 D1 DE69530910 D1 DE 69530910D1
Authority
DE
Germany
Prior art keywords
sialinic
derivative
compositions containing
medical compositions
medical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69530910A
Other languages
English (en)
Other versions
DE69530910T4 (de
DE69530910T2 (de
Inventor
Mamoru Koketsu
Masakazu Nishizono
Teruhiko Nitoda
Yuko Enoki
Hiroshi Kawanami
Raj Juneja
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiyo Kagaku KK
Original Assignee
Taiyo Kagaku KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiyo Kagaku KK filed Critical Taiyo Kagaku KK
Application granted granted Critical
Publication of DE69530910D1 publication Critical patent/DE69530910D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Peptides Or Proteins (AREA)
DE69530910A 1994-07-15 1995-07-14 Medizinische zusammensetzungen enthaltend ein sialinsäurederivat Expired - Fee Related DE69530910D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP18669994 1994-07-15
JP18670094 1994-07-15
PCT/JP1995/001415 WO1996002255A1 (fr) 1994-07-15 1995-07-14 Composition medicamenteuse contenant un derive d'acide sialique

Publications (1)

Publication Number Publication Date
DE69530910D1 true DE69530910D1 (de) 2003-07-03

Family

ID=26503920

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69530910A Expired - Fee Related DE69530910D1 (de) 1994-07-15 1995-07-14 Medizinische zusammensetzungen enthaltend ein sialinsäurederivat
DE69530910T Expired - Lifetime DE69530910T4 (de) 1994-07-15 1995-07-14 Medizinische zusammensetzungen enthaltend ein sialinsäurederivat

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69530910T Expired - Lifetime DE69530910T4 (de) 1994-07-15 1995-07-14 Medizinische zusammensetzungen enthaltend ein sialinsäurederivat

Country Status (6)

Country Link
US (1) US5834423A (de)
EP (1) EP0727216B1 (de)
JP (1) JP3930559B2 (de)
CA (1) CA2171614C (de)
DE (2) DE69530910D1 (de)
WO (1) WO1996002255A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6066323A (en) * 1994-02-02 2000-05-23 The United States Of America As Represented By The Secretary Of The Army Use of antibodies to sialidase as anti-infectious agents and anti-inflammatory agents
KR20000004990A (ko) * 1996-03-26 2000-01-25 마크 제이. 건더슨 알의 항염증성 조성물, 그의 단리 방법 및용도
EP1143981B1 (de) * 1998-12-29 2006-08-09 Glukor, Inc. Verwendung von n-glycolneuraminsäure und deren derivaten zur herstellung eines medikaments zur behandlung von hiv-infektionen
ID29150A (id) * 1999-01-15 2001-08-02 Entpr Ireland Cs Penggunaan lactobacillus salivarius
WO2000043019A2 (en) * 1999-01-19 2000-07-27 Dcv Inc Egg anti-inflammatory composition and method of treating and preventing inflammation
US20030092091A1 (en) * 2000-03-07 2003-05-15 Abrahamson Julie A. Sialoadhesin factor-2 antibodies
NL1017973C2 (nl) * 2000-05-10 2002-11-08 Tristem Trading Cyprus Ltd Inrichting.
WO2003012048A2 (en) * 2001-07-31 2003-02-13 Board Of Regents, University Of Texas System Antigens of and antibodies to translocated molecules of microorganisms and uses thereof
EP2272522B1 (de) * 2002-06-28 2017-09-06 Nestec S.A. Therapeutische Zusammensetzungen zur Verwendung bei der Prophylaxe oder Behandlung von Diarrhö
PL375071A1 (en) * 2002-10-11 2005-11-14 Wyeth Nutritional formulations containing synbiotic substances
FI20021989A0 (fi) * 2002-11-06 2002-11-06 Halina Miller-Podraza Korkean affiniteetin Helicobacter pylori-reseptorit ja niiden käyttö
TR201820053T4 (tr) * 2003-02-04 2019-01-21 Glytech Inc Şeker zinciri asparajin türevi üretmeye yönelik proses.
CN101139624B (zh) * 2006-09-06 2012-08-22 北京德青源农业科技股份有限公司 一种制备涎酸寡糖肽的方法
UA110325C2 (en) * 2009-07-03 2015-12-25 Australian Biomedical Company Pty Ltd Medicinal carbohydrates for treating respiratory conditions
WO2011027868A1 (ja) 2009-09-03 2011-03-10 公益財団法人野口研究所 １１糖シアリルオリゴ糖ペプチドの製造方法
JP5285022B2 (ja) * 2010-04-30 2013-09-11 旭化成株式会社 糖ペプチド誘導体及びその製造方法
JP5709157B2 (ja) * 2010-08-16 2015-04-30 国立大学法人 香川大学 糖鎖の製造方法
EP3510873A1 (de) 2010-12-31 2019-07-17 Abbott Laboratories Nährstoffzusammensetzungen mit oligosacchariden aus menschlicher milch und nukleotiden sowie verwendungen davon zur behandlung und/oder prävention von enteralen virusinfektionen
EP2658401A2 (de) 2010-12-31 2013-11-06 Abbott Laboratories Oligosaccharide aus menschlicher milch zur anregung des wachstums von probiotischen bakterien
SG10202110501RA (en) 2010-12-31 2021-11-29 Abbott Lab Methods For Decreasing The Incidence Of Necrotizing Enterocolitis In Infants, Toddlers, Or Children Using Human Milk Oligosaccharides
SG10201606878QA (en) 2010-12-31 2016-09-29 Abbott Lab Human milk oligosaccharides for modulating inflammation
BR112013016936A2 (pt) 2010-12-31 2019-09-24 Abbott Lab métodos de usar oligossacarídeos de leite humano para melhorar a saúde respiratória das vias aéreas
CN103379908B (zh) 2010-12-31 2020-02-14 雅培制药有限公司 使用人乳寡糖、维生素c和抗炎剂减少氧化应激的发病率的方法
CN103369974A (zh) 2010-12-31 2013-10-23 雅培制药有限公司 包含人乳低聚糖和长链多不饱和脂肪酸的营养型制剂以及其用途
US11446316B2 (en) 2011-07-22 2022-09-20 Abbott Laboratories Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
CA2846603A1 (en) 2011-08-29 2013-03-07 Abbott Laboratories Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
NL2007931C2 (en) * 2011-12-07 2013-06-10 Friesland Brands Bv Methods for providing sialylated oligosaccharides and products obtainable thereby.
TW201534613A (zh) * 2013-06-28 2015-09-16 Daiichi Sankyo Co Ltd 寡糖胜肽之純化方法
WO2016006700A1 (ja) * 2014-07-11 2016-01-14 学校法人東京理科大学 樹状細胞免疫受容体活性化剤、樹状細胞免疫受容体活性化方法、破骨細胞形成抑制剤、破骨細胞形成抑制方法、樹状細胞分化・増殖阻害剤、樹状細胞分化・増殖阻害方法、サイトカイン産生抑制剤、サイトカイン産生抑制方法、治療方法及びスクリーニング方法
JP6762027B2 (ja) * 2016-08-25 2020-09-30 株式会社雅嘉貿易 シアロオリゴ糖の製造方法とその利用
JP2019182757A (ja) * 2018-04-04 2019-10-24 旭化成株式会社 ９糖シアリルオリゴ糖ペプチド及びその製造方法
WO2020148422A1 (en) * 2019-01-18 2020-07-23 Université Catholique de Louvain Virus compositions
BR112023017365A2 (pt) 2021-03-12 2023-10-03 Daiichi Sankyo Co Ltd Glicano e método para produzir medicamento contendo glicano
JPWO2023074843A1 (de) 2021-10-29 2023-05-04
CN116407460A (zh) * 2021-12-30 2023-07-11 嘉必优生物技术（武汉）股份有限公司 皮肤外用组合物以及唾液酸在制备防过敏制剂中的应用
JP2024004736A (ja) * 2022-06-29 2024-01-17 雪印メグミルク株式会社 気管支炎を予防するための栄養組成物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK17885D0 (da) * 1985-01-14 1985-01-14 Karlsson Karl Anders Antiviralt middel
JPS63221104A (ja) * 1987-03-09 1988-09-14 Rikagaku Kenkyusho ガングリオシド関連化合物及びその製造法
JPH04363302A (ja) * 1991-02-22 1992-12-16 Rikagaku Kenkyusho ポリラクトサミン型糖脂質
JPH07502011A (ja) * 1991-06-10 1995-03-02 グライカムド　インコーポレイテッド 免疫抑制性および寛容原性のオリゴ糖誘導体
WO1993007291A1 (en) * 1991-10-11 1993-04-15 New York University Immunoglobulin d-associated glycans and uses thereof
CA2123213A1 (en) * 1991-11-11 1993-05-27 Magnusson, Hans Goran Ganglioside analogs
JP3042738B2 (ja) * 1992-03-31 2000-05-22 雪印乳業株式会社 ガングリオシドｇｍ３組成物及びその製造法
JP3100005B2 (ja) * 1992-07-28 2000-10-16 雪印乳業株式会社 ヒト免疫不全ウィルス感染・増殖抑制剤
JPH06145069A (ja) * 1992-11-06 1994-05-24 Nisshin Oil Mills Ltd:The ガングリオシドｇｍ３またはその類縁体を有効成分とする血管新生阻害剤
GB9422584D0 (en) * 1994-02-15 1995-01-04 Medical Res Council Immunomodulation using oligosaccharides

Also Published As

Publication number Publication date
EP0727216A1 (de) 1996-08-21
DE69530910T4 (de) 2005-07-14
CA2171614C (en) 2008-04-15
WO1996002255A1 (fr) 1996-02-01
DE69530910T2 (de) 2003-12-04
EP0727216A4 (de) 1998-05-20
CA2171614A1 (en) 1996-02-01
US5834423A (en) 1998-11-10
EP0727216B1 (de) 2003-05-28
JP3930559B2 (ja) 2007-06-13

Similar Documents

Publication Publication Date Title
DE69530910D1 (de) Medizinische zusammensetzungen enthaltend ein sialinsäurederivat
FI963421A (fi) Oraalisia apuainekoostumuksia
DK0799297T3 (da) Fortykkede persyresammensætninger
FI952932A (fi) Monomeeriset insuliinianalogivalmisteet
BR9508844A (pt) Composição oral
DK0799298T4 (da) Fortykkede persyresammensætninger
BR9506536A (pt) Composição oral
NO953961D0 (no) Antihypertriglyseridemisk sammensetning
BR9510467A (pt) Composições orais
FI962574A0 (fi) Mikrobisidinen koostumus
BR9510307A (pt) Composições orais
FI971856A (fi) Pitkitetysti vapauttavia oraalisia sisapridikoostumuksia
EE9600011A (et) Uudsed dialkoksü-püridinüül-bensimidasooli derivaadid
DE69521906D1 (de) Zahnhygiene - präparate
FI963631A (fi) Insektisidisia tehoainekoostumuksia
NO965233D0 (no) Deacetoksytaksol-derivat
ITMI942166A0 (it) Composizioni farmaceutiche miorilassanti
MA23731A1 (fr) Compositions detegentes
BR9509287A (pt) Composições microbicidas
NO970144L (no) Trifluormetylkinolinkarboksylsyre-derivat
ATA194094A (de) Artikulator
BR9510459A (pt) Composições orais
NO970747D0 (no) Sammensetninger
FI962738A0 (fi) Farmaseuttiset koostumukset
BR9502788A (pt) Comppsição inseticida

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee